Search results
Showing 391 to 405 of 641 results for prescribing
Evidence-based recommendations on ertugliflozin (Steglatro) with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes in adults.
point-of-care tests in decision-making is clinically and cost effective when prescribing antimicrobials in children, young people and...
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date
from guidance Clostridioides difficile infection: antimicrobial prescribing Number NG199 Date issued July 2021 Other details
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date
Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)
This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends how to support children and young people and their families and carers to maintain tight control of blood glucose to reduce the long-term risks associated with diabetes.
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date
This guideline covers optimising care for adults with multimorbidity (multiple long-term conditions) by reducing treatment burden (polypharmacy and multiple appointments) and unplanned care. It aims to improve quality of life by promoting shared decisions based on what is important to each person in terms of treatments, health priorities, lifestyle and goals. The guideline sets out which people are most likely to benefit from an approach to care that takes account of multimorbidity, how they can be identified and what the care involves.
This guideline covers how donor milk banks should recruit, screen and support women who donate breast milk. It also covers how milk banks should handle and process the breast milk they receive from donors. It aims to improve the safety of donor milk and operation of donor milk services.